|Study Description:||The goal of this clinical research study is to learn if BL-8040 in combination |
with cytarabine can help to control relapsed or refractory AML. The safety of
the study drug combination will also be studied.
BL-8040 is designed to help cancer cells move from the bone marrow into the
bloodstream, where they are exposed to chemotherapy (in this case, cytarabine).
Cytarabine is designed to insert itself into the DNA (genetic material) of
cancer cells and stop the DNA from repairing itself. This may cause the cancer
cells to die.